Amgen invests £50 million ($66 million) in Oxford Nanopore Technologies
Thu 18th October 2018 THOUSAND OAKS, Calif. and OXFORD, England – (Oct. 18, 2018) – Amgen (NASDAQ:AMGN) and Oxford Nanopore Technologies Ltd. today announced Amgen’s equity investment of £50 million ($66 million) in Oxford Nanopore, a privately-owned, UK-based company advancing a new generation of portable, real-time genetic sequencing technology. Oxford Nanopore has developed and brought to... Read more